Safety and efficacy of tandem <sup>131</sup>I‐metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma

Kelsey E. Johnson(University of Minnesota), Yaël P. Mossé(Children's Hospital of Philadelphia), Barbara McGlynn(Children's Hospital of Philadelphia), Diane Baniewicz(Children's Hospital of Philadelphia), Hongming Zhuang(Children's Hospital of Philadelphia), Jennifer Saggio(Children's Hospital of Philadelphia), John M. Maris(Children's Hospital of Philadelphia)
Pediatric Blood & Cancer
April 14, 2011
10.1002/pbc.23062
Cited by 61

Related Papers

Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma
|New England Journal of Medicine|2005|571
Activating Mutations of the Noonan Syndrome-Associated <b> <i>SHP2/PTPN11</i> </b> Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
|Cancer Research|2004|512
Prevalence and functional consequence of PHOX2B mutations in neuroblastoma
|Oncogene|2007|154
The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study
|PLoS Medicine|2020|131
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results
|Nature Medicine|2023|125